0.08Open0.08Pre Close0 Volume7 Open Interest8.00Strike Price0.00Turnover301.31%IV69.04%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.08Extrinsic Value100Contract SizeAmericanOptions Type0.1099Delta0.1077Gamma59.75Leverage Ratio-0.0290Theta0.0001Rho6.56Eff Leverage0.0011Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet